Related Experiment Video

Updated: Jul 4, 2025

Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis
10:52

Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis

Published on: December 17, 2010

14.7K

Reply to 'Comments on the first European guideline for paraneoplastic autoimmune multiorgan syndrome'

Roberto Maglie1, Giovanni Genovese2, Enno Schmidt3,4

  • 1Department of Health Sciences, Section of Dermatology, University of Florence, Florence, Italy.

Journal of the European Academy of Dermatology and Venereology : JEADV
|February 2, 2024
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

3.6K
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

12.3K

Related Experiment Videos

Last Updated: Jul 4, 2025

Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis
10:52

Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis

Published on: December 17, 2010

14.7K
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

3.6K
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

12.3K

Related Concept Videos

Autoimmune Disorders01:29

Autoimmune Disorders

439
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
439
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

92
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
92
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K

Articles linked to this work by shared authors, journal, and citation graph.

Oral Zinc Supplementation in Acne Vulgaris and Hidradenitis Suppurativa: An Updated Comprehensive Review.

Nutrients·2026

Efficacy and safety of subcutaneous efgartigimod with prednisone in moderate-to-severe pemphigus (ADDRESS): a global, phase III, randomised controlled, double-blind trial.

The British journal of dermatology·2026

Repigmentation Competence in Vitiligo: Integrating Immune, Regulatory, Regenerative, and Microenvironmental Axes.

Journal of personalized medicine·2026

European S2k guidelines for hidradenitis suppurativa/acne inversa Part 1. Epidemiology, diagnosis and clinical assessment.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Autoinflammatory Syndromes of Hidradenitis Suppurativa: Updates in Clinical Features, Emerging Associations, and Management.

Current rheumatology reports·2026

Shared Mechanistic Pathways in Bullous Pemphigoid, Chronic Spontaneous Urticaria, Prurigo Nodularis, and Chronic Prurigo of Unknown Origin: Implications for Targeted Therapies.

American journal of clinical dermatology·2026

Clinically relevant evidence on imaging and artificial intelligence in hidradenitis suppurativa.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Treatment strategies for interstitial granulomatous dermatitis: Systematic review and expert opinion.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Adverse pregnancy outcomes in women with atopic dermatitis: A systematic review and meta-analysis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Disease progression in hidradenitis suppurativa: A multidimensional framework.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Ezetimibe/bempedoic acid combination in statin-induced anti-HMGCR positive immune-mediated necrotizing myopathy: a case series.

Rheumatology (Oxford, England)·2026

Immunometabolic Score AISI, UHR, RDW-to-Triglycerides and LDL-c-to-HDL-c Ratios as Early Markers of Cardiometabolic Risk in a Young Mexican Population with Elevated Waist-to-Height Ratio.

Metabolic syndrome and related disorders·2026

A Rare Case of Possible Iron Overload and B12 Deficiency in Autoimmune Polyglandular Syndrome Type 3B.

Cureus·2026

Differences in retroactive interference response reveal sex-specific memory resilience in pre-symptomatic triple transgenic Alzheimer's disease mice.

Brain communications·2026

Recurrence of Vogt-Koyanagi-Harada Disease as Immune-Related Adverse Events Induced by an Immune Checkpoint Inhibitor.

Cureus·2026

Occult Late-Onset Systemic Lupus Erythematosus Presenting as Critical Multisystem Disease in a Male: A Diagnostic Challenge in the Intensive Care Unit.

Cureus·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us